Comorbidities as an element of multidimensional prognostic assessment of patients with chronic obstructive pulmonary disease

Journal of Physiology and Pharmacology

Volumn 59, Issue SUPPL. 6, 2008, Pages 297-301

  Grabicki, M ^a   Parysek, H ^a   Batura Gabryel, H ^a   Brodnicka, I ^b  

^a POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

^b Hospital of Pulmonary Diseases and Tuberculosis   (Poland)

Author keywords

BODE index; Comorbidities; COPD

Indexed keywords

ADULT; AGED; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMORBIDITY; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE EXACERBATION; FEMALE; FORCED EXPIRATORY VOLUME; HEART ARRHYTHMIA; HUMAN; HYPERTENSION; LEG EDEMA; LEG VARICOSIS; MAJOR CLINICAL STUDY; MALE; MORTALITY; MOTOR DYSFUNCTION; PNEUMONIA; PREVALENCE; PROGNOSIS; RATING SCALE; SMOKING; CROSS-SECTIONAL STUDY; LUNG FUNCTION TEST; MIDDLE AGED; PHYSIOLOGY; PREDICTION AND FORECASTING;

AGED; CROSS-SECTIONAL STUDIES; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RESPIRATORY FUNCTION TESTS;

EID: 64549142817     PISSN: 08675910     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2006; Available from URL: http://www.goldcopd.org.
2. Soriano JB, Visick GT, Muellerova H, Payvandi N, Hansell AL. Patterns of comorbidities in newly diagnosed COPD and asthma in primary care. Chest 2005; 128: 2099-2107.
3. Hasnis E, Bar-Shai M, Burbea Z, Reznick AZ. Cigarette smoke-induced NF-κB activation in human lymphocytes: the effect of low and high exposure to gas phase of cigarette smoke. J Physiol Pharmacol 2007; 58 Suppl 5: 263-274.
4. Mroz RM, Noparlik J, Chyczewska E, Braszko JJ, Holownia A. Molecular basis of chronic inflammation in lung diseases: new therapeutic approach. J Physiol Pharmacol 2007; 58 Suppl 5: 453-460.
5. Agusti AG. Systemic effects of chronic obstructive pulmonary disease. Proc Am Thorac Soc 2005; 2: 367-370.
6. World Health Report. Geneva: World Health Organization. Available from URL: http://www.who.int/whr/2000/en/statistics.htm; 2000.
7. Petty TL. Definition, epidemiology, course, and prognosis of COPD. Clin Cornerstone 2003; 5:1-10.
8. Anthonisen NR, Connett JE, Enright PL, Manfreda J. Lung Health Study Research Group. Hospitalizations and mortality in the Lung Health Study. Am J Respir Crit Care Med 2002; 166:333-339.
9. Vilkman S, Keistinen T, Tuuponen T, Kivela SL. Survival and cause of death among elderly chronic obstructive pulmonary disease patients after first admission to hospital. Respiration 1997; 64: 281-284.
10. McGarvey LP, John M, Anderson JA, Zvarich M, Wise RA. Ascertainment of cause-specific mortality in COPD: operations of the TORCH Clinical Endpoint Committee. Thorax 2007; 62:411-415.
11. Celli BR, Cote CG, Marin JM, Casanova C et al. The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med 2004; 350: 1005-1012.
12. Freeborne N, Lynn J, Desbiens NA. Insights about dying from the SUPPORT Project. The study to understand prognoses and preferences for outcomes and risk of treatment. J Am Geriatr Soc 2000; 48 Suppl 5: S199-S205.
13. van Manen JG, Bindels PJE, Ijzermans CJ, van der Zee JS, Bottema BJAM, Schade E. Prevalence of comorbidity in patients with a chronic airway obstruction and controls over the age of 40. J Clin Epidemiol 2001; 54: 287-293.
14. Incalzi RA, Fuso L, De Rosa M, et al. Co-morbidity contributes to predict mortality of patients with chronic obstructive pulmonary disease. Eur Respir J 1997; 10: 2794-2800.
15. Yeo J, Karimova G, Bansal S. Co-morbidity in older patients with COPD - its impact on health service utilization and quality of life, a community study. Age Aging 2006; 35: 33-37.